05:59 AM EDT, 10/06/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) shares rose more than 4% in premarket Monday after it announced Friday that it will present at the 30th Annual Congress of the World Muscle Society 2025 Congress, taking place on Oct. 7 to 11 in Vienna, Austria.

The company, which works on precision genetic medicine for rare diseases, said it will present results from several studies on Duchenne muscular dystrophy, as well as the progress on its programs across muscle, central nervous system and cardiac diseases.

Sarepta also said it will share updates from the assessment of cardiac outcomes in delandistrogene moxeparvovec clinical trials for Duchenne muscular dystrophy and acute liver injury mitigation and management in patients with Duchenne muscular dystrophy following administration of delandistrogene moxeparvovec, among others.

Price: 23.74, Change: +1.10, Percent Change: +4.86